论文部分内容阅读
膀胱肿瘤是泌尿系统最常见的恶性肿瘤。确诊时约有25%的患者属浸润性或转移性癌,其中50%最终将发生转移,预后较差[1]。浸润性膀胱癌一般采用根治性膀胱切除术。但是手术并发症多,术后因尿流改道等原因导致患者生活不便。上世纪八十年代,国外已进行浸润性膀胱癌保留膀胱综合治疗的临床研究,并取得满意的结果,并逐渐应用到临床[2]。国内保留膀胱手术并术后化疗的报道较少。本文回顾性分析我院2007年8月~2010年6月对
Bladder cancer is the most common malignancy of the urinary system. About 25% of patients diagnosed with invasive or metastatic cancer, of which 50% of the final transfer will occur, the prognosis is poor [1]. Invasive bladder cancer is usually treated by radical cystectomy. However, surgical complications and postoperative urinary diversion and other causes of inconvenience to patients. The eighties of last century, foreign countries have been bladder invasive bladder cancer retention clinical research, and achieved satisfactory results, and gradually applied to the clinical [2]. Domestic retained bladder surgery and postoperative chemotherapy less reported. This retrospective analysis of our hospital from August 2007 to June 2010 pairs